AtulKumarSinghalMDCPI, FACR

Rheumatology • Mesquite, TX

Geriatric Rheumatology

Medical Director

Join to view full profile

Dr. Singhal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Singhal's full profile

Already have an account?

Office
1600 Republic Pkwy
Ste 200
Mesquite, TX 75150
Phone+1 972-288-2600

Education & Training

University of Pennsylvania Health SystemFellowship, Rheumatology, 1992 - 1995
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1989 - 1992
All India Institute of Medical SciencesClass of 1987

Certifications & Licensure

TX State Medical License 1995 - 2026
NJ State Medical License 1994 - 1997
PA State Medical License 1992 - 1996

Clinical Trials

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) Start of enrollment: 2020 Jul 01
Recruiting
Phase 3
Roles: Contact
Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2021 Jan 11
Active, not recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) Start of enrollment: 2021 Oct 11
Recruiting
Phase 2

Publications & Presentations

PubMed

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized cont...
Ronald van Vollenhoven, Vibeke Strand, Tsutomu Takeuchi, Nilmo Chávez, Pablo Mannucci Walter
Arthritis Research & Therapy. 2024-07-29
2 citations
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.
Alan J Kivitz, Joel M Kremer, Clarence W Legerton 3rd, Luminita Pricop, Atul Singhal
Rheumatology and Therapy. 2024-06-01
210 citations
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 s...
Philip J. Mease, Désirée van der Heijde, Robert Landewé, Shephard Mpofu, Proton Rahman
Annals of the Rheumatic Diseases. 2018-03-17